APLS
Price
$17.44
Change
-$0.34 (-1.91%)
Updated
May 23 closing price
Capitalization
2.19B
79 days until earnings call
BLTE
Price
$61.00
Change
-$6.29 (-9.35%)
Updated
May 23 closing price
Capitalization
1.99B
74 days until earnings call
Interact to see
Advertisement

APLS vs BLTE

Header iconAPLS vs BLTE Comparison
Open Charts APLS vs BLTEBanner chart's image
Apellis Pharmaceuticals
Price$17.44
Change-$0.34 (-1.91%)
Volume$1.29M
Capitalization2.19B
Belite Bio
Price$61.00
Change-$6.29 (-9.35%)
Volume$27.82K
Capitalization1.99B
APLS vs BLTE Comparison Chart
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. BLTE commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and BLTE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (APLS: $17.44 vs. BLTE: $61.00)
Brand notoriety: APLS and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 46% vs. BLTE: 85%
Market capitalization -- APLS: $2.19B vs. BLTE: $1.99B
APLS [@Biotechnology] is valued at $2.19B. BLTE’s [@Biotechnology] market capitalization is $1.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, BLTE is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 5 TA indicator(s) are bullish while BLTE’s TA Score has 4 bullish TA indicator(s).

  • APLS’s TA Score: 5 bullish, 3 bearish.
  • BLTE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, APLS is a better buy in the short-term than BLTE.

Price Growth

APLS (@Biotechnology) experienced а -0.06% price change this week, while BLTE (@Biotechnology) price change was -5.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

APLS is expected to report earnings on Aug 11, 2025.

BLTE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($2.19B) has a higher market cap than BLTE($1.99B). BLTE YTD gains are higher at: -3.328 vs. APLS (-45.346). BLTE has higher annual earnings (EBITDA): -35.42M vs. APLS (-176.08M). APLS has higher revenues than BLTE: APLS (776M) vs BLTE (0).
APLSBLTEAPLS / BLTE
Capitalization2.19B1.99B110%
EBITDA-176.08M-35.42M497%
Gain YTD-45.346-3.3281,363%
P/E RatioN/AN/A-
Revenue776M0-
Total Cash358MN/A-
Total Debt470MN/A-
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSBLTE
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 19 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSSLX8.46N/A
N/A
Morgan Stanley Inst Inception L
MVTIX10.63-0.04
-0.37%
Transamerica Mid Cap Value Opps I
AFMCX12.27-0.07
-0.57%
Acuitas US Microcap Institutional
CNGAX60.54-0.41
-0.67%
American Funds New Economy 529A
RSEAX16.11-0.12
-0.74%
Russell Inv US Strategic Equity A

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ROIV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
-1.91%
ROIV - APLS
46%
Loosely correlated
-0.64%
NTLA - APLS
45%
Loosely correlated
-3.17%
BEAM - APLS
43%
Loosely correlated
-2.26%
DNLI - APLS
43%
Loosely correlated
-1.76%
CYTK - APLS
41%
Loosely correlated
+0.18%
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-9.35%
RAIN - BLTE
48%
Loosely correlated
-22.31%
ACOG - BLTE
24%
Poorly correlated
+5.18%
ALEC - BLTE
23%
Poorly correlated
-5.34%
HRMY - BLTE
22%
Poorly correlated
+0.12%
APLS - BLTE
22%
Poorly correlated
-1.91%
More